Sale

Diabetic Ulcer Treatment Market

Global Diabetic Ulcer Treatment Market Size, Share, Report: By Treatment Type: Wound Care Dressing, Wound care Devices, Active Therapies; By Grade; By Ulcer Types: Neuropathic Ulcers, Ischemic Ulcers, Neuro-Ischemic Ulcers, Others; By End User: Hospital Inpatient Settings, Others; Regional Analysis; Supplier Landscape; 2024-2032

Global Diabetic Ulcer Treatment Market Outlook

The global diabetic ulcer treatment market value was USD 5.52 billion in 2023, driven by the increasing prevalence of diabetes across the globe. The market size is anticipated to grow at a CAGR of 8.1% during the forecast period of 2024-2032 to achieve a value of USD 11.13 billion by 2032.

 

Rising Cases of Global Diabetes to Bolster the Market Growth of Diabetic Ulcer Treatment

The global market for diabetic ulcer treatment is majorly being driven by the increasing prevalence of diabetes. Diabetes is increasing at a startling rate around the world owing to adoption of sedentary lifestyles and unhealthy eating habits. As a result of this, ulcers caused by diabetes are thus becoming a significant factor contributing to the growth of the market. According to the American Diabetes Association (ADA), patients with diabetes are more prone to gum diseases resulting in a disruption in body’s blood sugar level and giving rise to mouth ulcers.

 

Global Diabetic Ulcer Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The development of novel techniques to treat mouth ulcers aided by robust pharmaceutical research and development (R&D) is thereby stimulating the growth of the market. Furthermore, diabetic foot ulcers are becoming a leading cause of concern and, if left untreated, can lead to leg amputation and death in severe cases. These factors are therefore invigorating the growth of the market.

 

Diabetic Ulcer Treatment: Market Segmentation

Diabetic ulcers are a side effect of chronic diabetes and are usually found in the feet or mouth of the patient. Diabetic patients who depend on insulin are more likely to develop ulcers. The most common types of treatment include wound care dressings and active therapies.

 

Global Diabetic Ulcer Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

On the basis of treatment type, the market can be divided into:

  • Wound Care Dressing
  • Wound Care Devices
  • Active Therapies

Wound care dressing can be further divided into antimicrobial dressings, film dressings, and alginate dressings, among others.

Wound care devices can be further segmented into negative pressure wound therapy, hyperbaric oxygen therapy, and ultrasound therapy, among others.

Active therapies can be sub-divided into skin grafts and substitutes, growth factors, and hemostatic agents and sealants, among others.

Based on grade, the market can be categorised into:

  • Grade 1
  • Grade 2
  • Grade 3
  • Grade 4
  • Grade 5

The market, based on end-suer, can be segmented into:

  • Hospital Inpatient Settings
  • Hospital Outpatient Settings
  • Community Health Centres
  • Home Health Care
  • Others

The EMR report looks into the regional markets of diabetic ulcer treatment like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

 

Global Diabetic Ulcer Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Advancements in Medical Technology to Aid the Market Growth of Diabetic Ulcer Treatment

The rise in the global market for diabetic ulcer treatment can be associated with the rising demand for cost-effective treatment options for addressing the concerns of diabetic ulcers. The growing advancements in medical and pharmaceutical technology, such as the introduction of biomaterials for wound healing like skin substitutions, extracellular matrix proteins, and other therapeutic agents, among other treatment options, are providing impetus to the market growth. The robust research programmes implemented in developing wound care products are further expected to promote the adoption of advanced treatment options for bettering the healing process of diabetic ulcers in the coming years. Moreover, the strong market penetration of leading industry players, rising awareness about treatment options, and the flourishing healthcare sector around the world are also expected to have a positive influence on the growth of the market.

 

Key Industry Players in the Global Diabetic Ulcer Treatment Market

The report presents a detailed analysis of the following key players in the global diabetic ulcer treatment market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions:

  • ConvaTec Group plc
  • Acelity L.P. Inc.
  • 3M Company
  • Smith and Nephew Plc.
  • B. Braun Melsungen Ag
  • Medline Industries, LP,
  • Medtronic Plc
  • Organogenesis Holdings Inc
  • Molnlycke Health Care AB
  • BSN Medical GMBH
  • Others

The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Treatment Type
  • Grade
  • Ulcer Types
  • End User
  • Region
Breakup by Treatment Type
  • Wound Care Dressing
  • Wound care Devices
  • Active Therapies
Breakup by Grade
  • Grade 1
  • Grade 2
  • Grade 3
  • Grade 4
  • Grade 5
Breakup by Ulcer Types
  • Neuropathic Ulcers
  • Ischemic Ulcers
  • Neuro-Ischemic Ulcers
  • Others
Breakup by End User
  • Hospital Inpatient Settings
  • Hospital Outpatient Settings
  • Community Health Centers
  • Home Healthcare
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • ConvaTec Group plc
  • Acelity L.P. Inc.
  • 3M Company
  • Smith and Nephew Plc.
  • B. Braun Melsungen Ag
  • Medline Industries, LP
  • Medtronic Plc
  • Organogenesis Holdings Inc
  • Molnlycke Health Care AB
  • BSN Medical GMBH
  • Integra LifeSciences Corporation
  • Tissue Regenix
  • Coloplast Corp
  • Cardinal Health.
  • 3M
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Diabetic Ulcer Overview

    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Diabetic Ulcer Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Diabetic Ulcer Treatment Epidemiology (2016-2031)
    5.3    Europe Diabetic Ulcer Epidemiology (2016-2031)
    5.4    Asia-Pacific Diabetic Ulcer Epidemiology (2016-2031)
    5.5    Latin America Diabetic Ulcer Epidemiology (2016-2031)
    5.6    Middle East & Africa Diabetic Ulcer Epidemiology (2016-2031)
6    Global Diabetic Ulcer Treatment Market Overview 
    6.1    Global Diabetic Ulcer Treatment Market Historical Value (2017-2023) 
    6.2    Global Diabetic Ulcer Treatment Market Forecast Value (2024-2032)
7    Global Diabetic Ulcer Treatment Market Landscape
    7.1    Diabetic Ulcer Treatment: Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Diabetic Ulcer Treatment: Product Landscape
        7.2.1    Analysis by Treatment Type
        7.2.2    Analysis by Grade
        7.2.3    Analysis by Ulcer Type
        7.2.4    Analysis by End User
8    Diabetic Ulcer Treatment Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Global Diabetic Ulcer Treatment Market Dynamics

    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model
    10.4    Key Demand Indicators 
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends  
    10.7    Value Chain Analysis
11    Global Diabetic Ulcer Treatment Market Segmentation
    11.1    Global Diabetic Ulcer Treatment Market by Treatment Type 
        11.1.1    Market Overview
        11.1.2    Wound Care Dressing
            11.1.2.1    Antimicrobial Dressings
            11.1.2.2    Film Dressings
            11.1.2.3    Alginate Dressings
            11.1.2.4    Others
        11.1.3    Wound care Devices
            11.1.3.1    Negative Pressure Wound Therapy
            11.1.3.2    Hyperbaric Oxygen Therapy
            11.1.3.3    Ultrasound Therapy
            11.1.3.4    Others
        11.1.4    Active Therapies
            11.1.4.1    Skin Grafts and Substitutes
            11.1.4.2    Growth Factors
            11.1.4.3    Hemostatic Agents and Sealants
            11.1.4.4    Other
    11.2    Global Diabetic Ulcer Treatment Market by Grade
        11.2.1    Market Overview
        11.2.2    Grade 1
        11.2.3    Grade 2
        11.2.4    Grade 3
        11.2.5    Grade 4
        11.2.6    Grade 5
    11.3    Global Diabetic Ulcer Treatment Market by Ulcer Types
        11.3.1    Market Overview
        11.3.2    Neuropathic Ulcers
        11.3.3    Ischemic Ulcers
        11.3.4    Neuro-Ischemic Ulcers
        11.3.5    Others
    11.4    Global Diabetic Ulcer Treatment Market by End User
        11.4.1    Market Overview
        11.4.2    Hospital Inpatient Settings
        11.4.3    Hospital Outpatient Settings
        11.4.4    Community Health Centers
        11.4.5    Home Healthcare
        11.4.6    Others
    11.5    Global Diabetic Ulcer Treatment Market by Region
        11.5.1    Market Overview
        11.5.2    North America
        11.5.3    Europe 
        11.5.4    Asia Pacific
        11.5.5    Latin America
        11.5.6    Middle East and Africa
12    North America Diabetic Ulcer Treatment Market
    12.1    Market Share by Country
    12.2    United States of America
    12.3    Canada
13    Europe Diabetic Ulcer Treatment Market
    13.1    Market Share by Country
    13.2    United Kingdom
    13.3    Germany
    13.4    France
    13.5    Italy
    13.6    Others
14    Asia Pacific Diabetic Ulcer Treatment Market
    14.1    Market Share by Country
    14.2    China
    14.3    Japan
    14.4    India
    14.5    ASEAN
    14.6    Australia
    14.7    Others
15    Latin America Diabetic Ulcer Treatment Market
    15.1    Market Share by Country
    15.2    Brazil
    15.3    Argentina
    15.4    Mexico
    15.5    Others
16    Middle East and Africa Diabetic Ulcer Treatment Market
    16.1    Market Share by Country
    16.2    Saudi Arabia
    16.3    United Arab Emirates
    16.4    Nigeria
    16.5    South Africa
    16.6    Others
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Patent Analysis
    18.1    Analysis by Type of Patent
    18.2    Analysis by Publication year
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Patent Age
    18.5    Analysis by CPC Analysis
    18.6    Analysis by Patent Valuation 
    18.7    Analysis by Key Players
19    Grants Analysis
    19.1    Analysis by year
    19.2    Analysis by Amount Awarded
    19.3    Analysis by Issuing Authority
    19.4    Analysis by Grant Application
    19.5    Analysis by Funding Institute
    19.6    Analysis by NIH Departments
    19.7    Analysis by Recipient Organization 
20    Clinical Trials Analysis
    20.1     Analysis by Trial Registration Year
    20.2    Analysis by Trial Status
    20.3    Analysis by Trial Phase
    20.4    Analysis by Therapeutic Area
    20.5    Analysis by Geography
21    Funding and Investment Analysis
    21.1    Analysis by Funding Instances
    21.2    Analysis by Type of Funding
    21.3    Analysis by Funding Amount
    21.4    Analysis by Leading Players
    21.5    Analysis by Leading Investors
    21.6    Analysis by Geography
22    Partnership and Collaborations Analysis
    22.1    Analysis by Partnership Instances
    22.2    Analysis by Type of Partnership
    22.3    Analysis by Leading Players
    22.4    Analysis by Geography
23    Supplier Landscape
    23.1    ConvaTec Group plc
        23.1.1    Financial Analysis
        23.1.2    Product Portfolio
        23.1.3    Demographic Reach and Achievements
        23.1.4    Mergers and Acquisitions
        23.1.5    Certifications
    23.2    Acelity L.P. Inc.
        23.2.1    Financial Analysis
        23.2.2    Product Portfolio
        23.2.3    Demographic Reach and Achievements
        23.2.4    Mergers and Acquisitions
        23.2.5    Certifications
    23.3    3M Company
        23.3.1    Financial Analysis
        23.3.2    Product Portfolio
        23.3.3    Demographic Reach and Achievements
        23.3.4    Mergers and Acquisitions
        23.3.5    Certifications
    23.4    Smith and Nephew Plc.
        23.4.1    Financial Analysis
        23.4.2    Product Portfolio
        23.4.3    Demographic Reach and Achievements
        23.4.4    Mergers and Acquisitions
        23.4.5    Certifications
    23.5    B. Braun Melsungen Ag
        23.5.1    Financial Analysis
        23.5.2    Product Portfolio
        23.5.3    Demographic Reach and Achievements
        23.5.4    Mergers and Acquisitions
        23.5.5    Certifications
    23.6    Medline Industries, LP
        23.6.1    Financial Analysis
        23.6.2    Product Portfolio
        23.6.3    Demographic Reach and Achievements
        23.6.4    Mergers and Acquisitions
        23.6.5    Certifications
    23.7    Medtronic Plc
        23.7.1    Financial Analysis
        23.7.2    Product Portfolio
        23.7.3    Demographic Reach and Achievements
        23.7.4    Mergers and Acquisitions
        23.7.5    Certifications
    23.8    Organogenesis Holdings Inc
        23.8.1    Financial Analysis
        23.8.2    Product Portfolio
        23.8.3    Demographic Reach and Achievements
        23.8.4    Mergers and Acquisitions
        23.8.5    Certifications
    23.9    Molnlycke Health Care AB
        23.9.1    Financial Analysis
        23.9.2    Product Portfolio
        23.9.3    Demographic Reach and Achievements
        23.9.4    Mergers and Acquisitions
        23.9.5    Certifications
    23.10    BSN Medical GMBH
        23.10.1    Financial Analysis
        23.10.2    Product Portfolio
        23.10.3    Demographic Reach and Achievements
        23.10.4    Mergers and Acquisitions
        23.10.5    Certifications
    23.11    Integra LifeSciences Corporation
        23.11.1    Financial Analysis
        23.11.2    Product Portfolio
        23.11.3    Demographic Reach and Achievements
        23.11.4    Mergers and Acquisitions
        23.11.5    Certifications
    23.12    Tissue Regenix
        23.12.1    Financial Analysis
        23.12.2    Product Portfolio
        23.12.3    Demographic Reach and Achievements
        23.12.4    Mergers and Acquisitions
        23.12.5    Certifications
    23.13    Coloplast Corp
        23.13.1    Financial Analysis
        23.13.2    Product Portfolio
        23.13.3    Demographic Reach and Achievements
        23.13.4    Mergers and Acquisitions
        23.13.5    Certifications
    23.14    Cardinal Health.
        23.14.1    Financial Analysis
        23.14.2    Product Portfolio
        23.14.3    Demographic Reach and Achievements
        23.14.4    Mergers and Acquisitions
        23.14.5    Certifications
    23.15    3M
        23.15.1    Financial Analysis
        23.15.2    Product Portfolio
        23.15.3    Demographic Reach and Achievements
        23.15.4    Mergers and Acquisitions
        23.15.5    Certifications
24    Diabetic Ulcer Treatment - Distribution Model (Additional Insight)
    24.1    Overview 
    24.2    Potential Distributors 
    24.3    Key Parameters for Distribution Partner Assessment 
25    Key Opinion Leaders (KOL) Insights (Additional Insight)
26    Company Competitiveness Analysis (Additional Insight)

    26.1    Very Small Companies
    26.2    Small Companies
    26.3    Mid-Sized Companies
    26.4    Large Companies
    26.5    Very Large Companies
27    Payment Methods (Additional Insight)
    27.1    Government Funded
    27.2    Private Insurance
    27.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the global market of diabetic ulcer treatment attained a value of USD 5.52 billion.

The market is anticipated to grow at a CAGR of 8.1% during the forecast period of 2024-2032 to reach a value of USD 11.13 billion by 2032.

The market is being driven by the increasing cases of diabetes due to unhealthy lifestyles resulting in obesity and the corresponding demand for effective treatment against mouth and foot ulcers.

The growth in the market can be associated with the advancements in medical technology leading to the introduction of biomaterials for skin healing.

The major regional markets for diabetic ulcer treatment are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

The different treatment types of diabetic ulcer include wound care dressing, wound care devices, and active therapies.

The significant grades of diabetic ulcer treatment are grade 1, grade 2, grade 3, grade 4, and grade 5.

The major end users of diabetic ulcer treatment are hospital inpatient settings, hospital outpatient settings, community health centres, and home health care, among others.

The major players in the industry are ConvaTec Group plc, Acelity L.P. Inc., 3M Company, Smith and Nephew Plc., B. Braun Melsungen Ag, Medline Industries, LP, Medtronic Plc, Organogenesis Holdings Inc, Molnlycke Health Care AB, and BSN Medical GMBH, among others.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER